Funding Information: The IRON-PATH II study was sponsored by CSL Vifor with coordination by Bellvitge Biomedical Research Institute (IDIBELL). The sponsor did not participate in the design of this study nor data analysis. An independent data and safety monitoring committee reviewed the data every 6 months. This study was approved by the local ethics committees for clinical research at each participating center ...
Funding Information: This research was funded by CIBER (Consorcio Centro de Investigaci\u00F3n Biom\u00E9dica en Red) (CB07/08/0028) and the Department of Research and Universities of the Generalitat of Catalonia (SGR-00815). Publisher Copyright: © 2025 by the authors.; Heart failure (HF), particularly of an ischemic etiology, is steadily increasing worldwide. Non-anemic iron deficiency (ID) is highly prevalent...